In the goblet-cell-count results, Lin et al. showed that the use of HU-210, a non-selective agonist of CB1 and CB2 receptors, prevented the decrease in goblet cells in the colon caused by colitis induced by dextran sulfate sodium (DSS) [23]. Here, CNR1 is linked to colitis.